Healthcare Analytics
Europe
Updated
Reviewed by Chandani Patel
Europe Menopause Care Platforms Market Industry Trends and Forecast to 2034: Segmented by (Service, Payer, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034
Values shown here are placeholder estimates, not researched figures. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.
Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.
$603.6 Mn total, 2026–2034
| Year | Market size | Change that year | Since 2025 |
|---|---|---|---|
| 2024 (estimate) | $187.8 Mn | — | — |
| 2025 (base) | $217.6 Mn | +$29.9 Mn | — |
| 2026 (forecast) | $252.2 Mn | +$34.6 Mn | +15.9% |
| 2027 (forecast) | $292.3 Mn | +$40.1 Mn | +34.3% |
| 2028 (forecast) | $338.8 Mn | +$46.5 Mn | +55.7% |
| 2029 (forecast) | $392.7 Mn | +$53.9 Mn | +80.4% |
| 2030 (forecast) | $455.1 Mn | +$62.4 Mn | +109.1% |
| 2031 (forecast) | $527.5 Mn | +$72.4 Mn | +142.4% |
| 2032 (forecast) | $611.3 Mn | +$83.9 Mn | +180.9% |
| 2033 (forecast) | $708.5 Mn | +$97.2 Mn | +225.6% |
| 2034 (forecast) | $821.2 Mn | +$112.7 Mn | +277.4% |
Placeholder estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.
| Market size, 2025 | $217.6 Mn placeholder estimate |
|---|---|
| Forecast, 2034 | $821.2 Mn placeholder estimate |
| Growth (CAGR), 2025–2034 | 15.9% placeholder estimate |
| Years | 2024 historical · 2025 base year · 2026–2034 forecast |
| Segments | Service, payer and end user (see all) |
| Key players | Midi Health, Gennev, Evernow, Elektra Health, Maven Clinic and 1 more (see all) |
| Regulator in Europe | EU MDRSource: European Commission, medical devices. Checked 14 Nov 2026. |
| Formats | PDF, PPTX, XLSX |
Sizes and growth here are placeholder estimates, not researched figures. Researched figures come with the full report.
Menopause care platforms offer online access to menopause specialists, prescriptions, symptom tracking and coaching.
Key segments of the menopause Care Platforms market include service (Telehealth Consultations, Prescription Delivery and Symptom Tracking Apps) and payer (Direct-to-Consumer and Employer Benefits).
Greater awareness of women's health needs, more funding for female-focused research, later pregnancies and an ageing female population are driving the menopause Care Platforms market. New products designed around women's biology and digital care are improving access.
Femtech, personalised care and new treatments for under-served conditions open strong growth for the menopause Care Platforms market, especially as employers and payers add women's health benefits.
Under-diagnosis, stigma around some conditions, limited insurance coverage and a long history of under-research in women's health hold back the menopause Care Platforms market.
The menopause Care Platforms market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.
Under the EU Medical Device Regulation (MDR), software used for diagnosis or treatment counts as a medical device.[1] In some of the countries we cover here, rules for health software come from EU MDR and ANSM (France)[1], BfArM (DiGA) (Germany)[2], EU MDR and Ministry of Health (Italy)[1], EU MDR and AEMPS (Spain)[1] and MHRA (UK)[3]. Each country runs its own health system and decides prices and reimbursement; since January 2025, EU countries also share joint clinical assessments of some new medicines.[4]
[1] European Commission, medical devices. Checked 14 Nov 2026.
[2] BfArM DiGA directory. Checked 14 Nov 2026.
[3] Medicines and Healthcare products Regulatory Agency. Checked 14 Nov 2026.
[4] European Commission, health technology assessment. Checked 14 Nov 2026.
Rules on software as a medical device, data privacy (such as HIPAA and GDPR) and telehealth reimbursement shape the menopause Care Platforms market. Government digital health programs in Europe are speeding up adoption.
What doctors and scientists are doing in Menopause Care Platforms right now, from free public sources.
Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.
From our blog
Europe
Europe
Europe
Europe
Europe
Europe
Pharmaceuticals · Europe
Healthcare Services · Europe
Pharmaceuticals · Europe
Medical Devices · Europe
Pharmaceuticals · Europe
Pharmaceuticals · Europe